Twist Bioscience

Forecast & Rating13 analysts currently cover Twist Bioscience, with about 69.2% giving a positive rating — meaning they expect the stock to rise. The average price target is $163.67, about 17.0% upside from the current price of $139.92. Price targets range from $45.00 to $215.00 — a wide spread, showing clear disagreement over just how much Twist Bioscience can rise. Historically, about 77.7% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Twist Bioscience closely still see room for the stock to rise. Data as of Oct 15, 2026; for reference only and not investment advice.